Unique ID issued by UMIN | UMIN000043661 |
---|---|
Receipt number | R000049858 |
Scientific Title | Follow-up study of "Evaluation for new Phosphate Iron-based binder , Sucroferric Oxyhydroxide in Dialysis patient for E.B.M (EPISODE)" |
Date of disclosure of the study information | 2021/05/01 |
Last modified on | 2023/09/19 16:57:35 |
Follow-up study of "Evaluation for new Phosphate Iron-based binder, Sucroferric Oxyhydroxide in Dialysis patient for E.B.M (EPISODE)"
Follow-up study of EPISODE
Follow-up study of "Evaluation for new Phosphate Iron-based binder , Sucroferric Oxyhydroxide in Dialysis patient for E.B.M (EPISODE)"
Follow-up study of EPISODE
Japan |
hyperphosphatemia
Nephrology |
Others
NO
Follow-up of patients enrolled in the EPISODE study and given assigned medications after the study ends to examine the incidence of CVD events between each factor (sucrose hydroxide and lanthanum carbonate drug groups, usual care and strict care groups)
Others
Examine changes in laboratory test values between the two groups
Onset of CVD events between factors (drug group, treatment group) after completion of EPISODE study
Fluctuations in laboratory test values between factors (drug group, treatment group) after completion of EPISODE study
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients enrolled in the EPISODE trial and receiving the allocation drugs
2. Patients who can be followed up
3. Patients given written informed consent. (opt-out is also available)
Research investigators or research sharing investigators have determined to the patient is inappropriate as a subject of the study.
156
1st name | Yoshitak |
Middle name | ISAKA |
Last name | ISAKA |
Osaka University Graduate School of Medicine
Department of Nephrology
565-0871
2-2, Yamada-oka, Suita
06-6879-3857
isaka@kid.med.osaka-u.ac.jp
1st name | Kiyomi |
Middle name | |
Last name | Kanda |
The Japan Clinical Research Forum
Secretariat
532-0004
2-6-16-405 Nishimiyahara, Yodogawa-ku, Osaka
06-6398-5192
e-extension@jarf.or.jp
Osaka University Graduate School of Medicine Department of Nephrology
Kissei Pharmaceutical Co., Ltd.
Profit organization
Japan
Osaka University Graduate School of Medicine
2-2, Yamada-oka, Suita
-2
rinri@hp-crc.med.osaka-u.ac.jp
NO
2021 | Year | 05 | Month | 01 | Day |
Unpublished
Preinitiation
2021 | Year | 03 | Month | 17 | Day |
2021 | Year | 05 | Month | 01 | Day |
2022 | Year | 03 | Month | 31 | Day |
observational study
2021 | Year | 03 | Month | 18 | Day |
2023 | Year | 09 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049858
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |